PL309359A1
Pyrazolopyrimidines as compounds acting as antagonists of corticotrophin releasing factor
Abstract
A compound of the formula:and the pharmaceutically acceptable acid addition salts thereof, whereinA is NR1R2, CR1R2R11, or C(=CR1R12)R2, NHCR1R2R11, OCR1R2R11, SCR1R2R11, NHNR1R2, CR2R11NHR1, CR2R11OR1, CR2R11SR1 or C(O)R2;wherein the rest of the variables are herein below defined, used for inflammatory disorders.
Term
Term ended
Projected expiry passed 26 November 2013, 12.8 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
45 members in 27 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 99222992 | United States of America | A | |
| 99222992 | United States of America | A | |
| 9311333 | United States of America | W | |
| 9311333 | United States of America | W | |
| 992229 | – | – | – |
| US9311333 | – | – | – |
| US19920992229 | – | – | – |
| WO1993US11333 | – | – | – |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| IL107944D0 | Israel | D0 | |
| HU9303613D0 | Hungary | D0 | |
| FI935675A | Finland | A | |
| CA2150709A1 | Canada | A1 | |
| WO9413677A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5728194A | Australia | A | |
| CN1094048A | China | A | |
| ZA939405B | South Africa | B | |
| NO952399D0 | Norway | D0 | |
| NO952399L | Norway | L | |
| PL309359A1This record | Poland | A1 | |
| EP0674642A1 | European Patent Office (EPO) | A1 | |
| JPH07509728A | Japan | A | |
| HUT70426A | Hungary | A | |
| CZ158695A3 | Czechia | A3 | |
| KR950704319A | Republic of Korea | A | |
| CN1034175C | China | C | |
| NZ259114A | New Zealand | A | |
| AU680226B2 | Australia | B2 | |
| EG20273A | Egypt | A | |
| RU2124016C1 | Russian Federation | C1 | |
| KR0167395B1 | Republic of Korea | B1 | |
| JP2862375B2 | Japan | B2 | |
| CA2150709C | Canada | C | |
| BR9307648A | Brazil | A | |
| NO305437B1 | Norway | B1 | |
| TW370529B | Taiwan Province of China | B | |
| PL177028B1 | Poland | B1 | |
| KR100225720B1 | Republic of Korea | B1 | |
| EP0674642B1 | European Patent Office (EPO) | B1 | |
| AT195738T | Austria | T | |
| ATE195738T1 | Austria | T1 | |
| DK0674642T3 | Denmark | T3 | |
| DE69329296D1 | Germany | D1 | |
| CZ287319B6 | Czechia | B6 | |
| FI105920B | Finland | B | |
| ES2150482T3 | Spain | T3 | |
| IL107944A | Israel | A | |
| DE69329296T2 | Germany | T2 | |
| GR3034507T3 | Greece | T3 | |
| PT674642E | Portugal | E | |
| US6218397B1 | United States of America | B1 | |
| TW444018B | Taiwan Province of China | B | |
| HU221507B | Hungary | B | |
| MY115300A | Malaysia | A |
Numbers
- Publication, DOCDB
- 309359
- Publication, EPODOC
- PL309359
- Application
- 93309359
- Application, DOCDB
- 30935993
- Application, EPODOC
- PL19930309359
Titles
- English
- PYRAZOLOPYRIMIDINES AS COMPOUNDS ACTING AS ANTAGONISTS OF CORTICOTROPHIN RELEASING FACTOR
Classification
- CPC, 14
- C07D487/04
- A61K31/505
- A61P1/00
- A61P11/06
- A61P15/00
- A61P25/00
- A61P25/24
- A61P25/26
- A61P25/28
- A61P29/00
- A61P31/18
- A61P35/00
- A61P37/00
- A61P37/06
- IPC, 11
- A61K31 505
- A61K31 519
- A61P1 00
- A61P25 24
- A61P25 26
- A61P25 28
- A61P29 00
- A61P37 06
- C07D231 00
- C07D239 00
- C07D487 04